KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) EBIT Margin (2016 - 2025)

Bausch Health Companies' EBIT Margin history spans 17 years, with the latest figure at 16.95% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 485.0% year-over-year to 16.95%; the TTM value through Dec 2025 reached 17.66%, up 160.0%, while the annual FY2025 figure was 17.66%, 160.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 16.95% at Bausch Health Companies, down from 23.09% in the prior quarter.
  • Across five years, EBIT Margin topped out at 27.19% in Q3 2021 and bottomed at 12.86% in Q2 2021.
  • The 5-year median for EBIT Margin is 12.86% (2024), against an average of 10.5%.
  • The largest annual shift saw EBIT Margin tumbled -2323bps in 2021 before it surged 2579bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 5.07% in 2021, then crashed by -312bps to 10.76% in 2022, then surged by 240bps to 15.03% in 2023, then skyrocketed by 45bps to 21.81% in 2024, then dropped by -22bps to 16.95% in 2025.
  • Per Business Quant, the three most recent readings for BHC's EBIT Margin are 16.95% (Q4 2025), 23.09% (Q3 2025), and 17.55% (Q2 2025).